Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$6,851,771
-$965,448 QoQ
Shares Held
284,542
+2.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#513
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WOODMONT INVESTMENT COUNSEL LLC holds $91,634,066 across 9 Drug Manufacturers - General names. PFE ranks #4 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,183 | $26,606,957 | |
| 2 | JNJ |
Johnson & Johnson
|
92,061 | $23,380,732 | |
| 3 | MRK |
Merck & Co., Inc.
|
173,179 | $22,253,501 | |
| 4 | PFE |
Pfizer Inc
This page
|
284,542 | $6,851,771 | |
| 5 | ABBV |
AbbVie Inc.
|
22,718 | $5,716,757 | |
| 6 | NVS |
Novartis AG
|
27,118 | $4,249,932 | |
| 7 | NVO |
Novo Nordisk A S
|
27,438 | $1,315,377 | |
| 8 | AMGN |
Amgen Inc
|
1,805 | $653,626 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,851,771 | 284,542 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $7,817,219 | 278,391 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $6,645,834 | 266,901 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $6,518,217 | 255,817 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $5,973,948 | 246,450 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $6,841,318 | 269,981 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $6,711,930 | 252,994 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,583,531 | 227,489 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $4,534,578 | 162,065 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,331,498 | 120,054 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $3,085,453 | 107,171 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $4,503,424 | 135,768 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $4,780,871 | 130,340 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $5,376,256 | 131,771 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $6,869,336 | 134,062 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $5,890,008 | 134,598 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $6,586,833 | 125,631 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $6,361,342 | 122,877 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,153,305 | 104,205 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $4,438,330 | 103,193 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,962,247 | 101,181 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,559,669 | 98,252 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,382,470 | 91,890 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,038,573 | 82,795 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,678,132 | 81,900 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,513,113 | 76,995 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||